BrandywineGLOBAL Valuation Multiples
Discover BrandywineGLOBAL's revenue and EBITDA valuation multiples and investment history.
BrandywineGLOBAL Overview
About BrandywineGLOBAL
BrandywineGLOBAL - Global Income Opportunities Fund Inc is a non-diversified, closed-end management investment company. The primary investment objective is to provide current income. The secondary investment objective is capital appreciation. The Fund seeks to achieve its investment objectives by investing, under normal market conditions, at least 80% of its assets in world-wide fixed-income securities.
Founded
2010
HQ
Employees
N/A
Website
Financials (FY)
EV
$207M
Valuation Multiples
Start free trial
BrandywineGLOBAL Financials
BrandywineGLOBAL reported last fiscal year revenue of $17M.
In the same fiscal year, BrandywineGLOBAL generated $15M in net income.
BrandywineGLOBAL P&L
In the most recent fiscal year, BrandywineGLOBAL reported revenue of $17M and net income of $15M.
BrandywineGLOBAL is profitable as of last fiscal year, with net margin of 92%.
Financial data powered by Morningstar, Inc.
BrandywineGLOBAL Stock Performance
BrandywineGLOBAL has current market cap of $131M, and enterprise value of $207M.
Market Cap Evolution
BrandywineGLOBAL's stock price is $7.79.
BrandywineGLOBAL share price increased by 0.8% in the last 30 days, and decreased by 9.6% in the last year.
BrandywineGLOBAL has an EPS (earnings per share) of $0.92.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $207M | $131M | 0.4% | 0.8% | -2.6% | -9.6% | $0.92 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBrandywineGLOBAL Valuation Multiples
BrandywineGLOBAL trades at 12.3x EV/Revenue multiple.
BrandywineGLOBAL Financial Valuation Multiples
As of August 8, 2026, BrandywineGLOBAL has market cap of $131M and EV of $207M.
BrandywineGLOBAL has a P/E ratio of 8.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BrandywineGLOBAL Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
BrandywineGLOBAL Margins & Growth Rates
In the most recent fiscal year, BrandywineGLOBAL reported net margin of 92%.
BrandywineGLOBAL Margins
BrandywineGLOBAL Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
BrandywineGLOBAL Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
BrandywineGLOBAL Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all BrandywineGLOBAL competitors and their valuation data. Start Free Trial | ||||||
Investments by BrandywineGLOBAL
BrandywineGLOBAL has invested in 6 companies to date.
Latest investment by BrandywineGLOBAL was on July 28th 2026. BrandywineGLOBAL invested in Soter Insure in their Series B round.
Latest Investments by BrandywineGLOBAL
| Description | Soter Insure is an insurance company that offers coverage products designed for the cryptocurrency and blockchain sector to support institutional standards and wider industry uptake. | Glacis Labs is a developer of cross-chain middleware protocol that automates risk management for DeFi transactions across Ethereum, Solana, and Cosmos. Its SDK enables developers to set slippage limits, MEV protection, and oracle validations in one integration. Launched in 2023 and based in Dubai, Glacis processes $500 million in monthly volume for protocols like Aave and Uniswap. The protocol uses zero-knowledge proofs for private bridging. | Lycia Therapeutics is a South San Francisco-based biotechnology firm advancing lysosomal targeting chimeras platform to degrade disease-causing extracellular proteins. Its LYTAC technology addresses targets inaccessible to traditional drugs, developing therapies for neurodegenerative disorders, cancer, and autoimmune diseases. Founded in 2020, the company raised significant venture funding from investors like Versant Ventures and The Column Group. | - | |
| HQ Country |  |  | | - | |
| HQ City | Abu Dhabi | Wilmington, DE | San Francisco, CA | - | |
| Deal Date | 28 Jul 2026 | 14 Jul 2026 | 24 Jun 2026 | 23 Jun 2026 | |
| Round | Series B | Seed | Series D | Seed | |
| Raised | undisclosed | $7M | $75M | $6M | |
| Investors | BrandywineGLOBAL; Galaxy Digital; BH Digital; Coinbase Ventures | Techni Ventures; BrandywineGLOBAL; A.GAIN Capital; Coinbase Ventures; Faction; Protein Capital | BrandywineGLOBAL; RTW Investments; Balyasny Asset Management; HBM Healthcare Investments; Invus; Eli Lilly; Adage Capital Management; OrbiMed; Janus Henderson Investors; Venrock Healthcare Capital Partners | BrandywineGLOBAL; Avi Felman; jmo ; Paper Ventures; Flow Traders; Alumni Ventures; Daedalus Angel Syndicate; Selini Capital; Polychain; Proxima Investments; GS Futures; Nomad Capital | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all BrandywineGLOBAL investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BrandywineGLOBAL
| When was BrandywineGLOBAL founded? | BrandywineGLOBAL was founded in 2010. |
| Where is BrandywineGLOBAL headquartered? | BrandywineGLOBAL is headquartered in United States. |
| Is BrandywineGLOBAL publicly listed? | Yes, BrandywineGLOBAL is a public company listed on NYSE. |
| What is the stock symbol of BrandywineGLOBAL? | BrandywineGLOBAL trades under BWG ticker. |
| When did BrandywineGLOBAL go public? | BrandywineGLOBAL went public in 2012. |
| Who are competitors of BrandywineGLOBAL? | BrandywineGLOBAL main competitors include |
| What is the current market cap of BrandywineGLOBAL? | BrandywineGLOBAL's current market cap is $131M. |
| What is the current revenue of BrandywineGLOBAL? | BrandywineGLOBAL's last fiscal year revenue is $17M. |
| What is the current EV/Revenue multiple of BrandywineGLOBAL? | Current revenue multiple of BrandywineGLOBAL is 12.3x. |
| Is BrandywineGLOBAL profitable? | No, BrandywineGLOBAL is not profitable. |
| How many companies BrandywineGLOBAL has acquired to date? | BrandywineGLOBAL hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies BrandywineGLOBAL has invested to date? | As of August 2026, BrandywineGLOBAL has invested in 6 companies. |
| What was the last BrandywineGLOBAL investment? | On 28th July 2026 BrandywineGLOBAL invested in Soter Insure, participating in a Series B round, alongside Galaxy Digital, BH Digital, and Coinbase Ventures. |
| In what companies BrandywineGLOBAL invested in? | BrandywineGLOBAL invested in Astranis, Stord, Lycia Therapeutics, Glacis Labs, Cambrian, and Soter Insure. |
Lists including BrandywineGLOBAL
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.